Case Study: Prohemia® Increases Hemoglobin 27% in 2 Months

Prohemia® case study shows dramatic blood building effects in an 82-year-old female with anemia.

METHODS: An 82-year-old female with anemia agreed to participate in a case study to help demonstrate the efficacy of Prohemia® to support healthy blood levels. Four (4) Prohemia® capsules were ingested daily for two (2) months. Hematocrit and hemoglobin levels were measured after two months of continuous Prohemia® use.

RESULTS: Following two months of Prohemia® use, the subject’s hematocrit and hemoglobin improved to healthy normal levels.

 

Hemoglobin
(grams/dL)

Hematocrit
(%)

Before Prohemia®

9.3
(anemic)

30.5
(anemic)

After Prohemia®

11.8
(normal)

36.2
(normal)

CONCLUSION: Although limited to a single subject, this anemic subject showed dramatic improvements in blood levels at two (2) months. Specifically, hemoglobin levels increased 27% and hematocrit increased 19%. This anemic subject’s blood levels returned to healthy normal levels after two months of Prohemia® use.

This case study also agrees with previous published clinical studies that showed potent increases in erythropoietin (EPO) levels following ingestion of the ingredients found in Prohemia®.

*Results may vary and the case study results cannot be expected in 100% of Prohemia users.